Catherine Strickland, M.D.
NPI 1154510410 · Family Medicine Physician · Rome, GA
Enrolled with Medicare as Practitioner - Family Practice · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1154510410
- Entity type
- Individual
- Primary specialty
- Family Medicine PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 065819 (GA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,006 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 215 | $119 |
| Detection Test By Immunoassay With Direct Visual Observation for Influenza Virus87804 | 156 | $16 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 132 | $9 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 83 | $13 |
| Detection Test By Immunoassay With Direct Visual Observation for Streptococcus, Group a (strep)87880 | 79 | $16 |
| Detection Test By Immunoassay Technique for Severe Acute Respiratory Syndrome Coronavirus87426 | 73 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Prednisone | 169 | 166 |
| Doxycycline Monohydrate | 82 | 81 |
| Denosumabbrand: Prolia | 61 | 33 |
| Cefdinir | 27 | 27 |
| Temazepam | 25 | — |
| Oseltamivir Phosphate | 21 | 20 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 21 | 20 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$120 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-10-23
- Last updated
- 2023-03-10
- Certified
- 2023-03-10
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.